Sequencing reactions
Ended Awarded Last action
- Contract number
- HHSN26100001
- Awardee
-
Genewiz, LLC UEI HAYFEH7AD428 Part of Azenta, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $4,998
Award facts
- Contract value 100% obligated
- $4,997.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541380 Testing Laboratories and Services
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- South Plainfield, NJ 07080, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$3 | |
| Funding Only Action | $1,000 | |
| Other Administrative Action | $1,000 | |
| Funding Only Action | $1,000 | |
| Funding Only Action | $1,000 | |
| Original award | $1,000 |
About this award
Genewiz, LLC, a subsidiary of Azenta, Inc., was awarded a $4,997.50 firm fixed-price call under a Blanket Purchase Agreement (BPA) by the National Cancer Institute for sequencing reactions services. The contract, issued on November 2, 2015, with an ultimate completion date of September 30, 2017, was performed at Genewiz's facility in South Plainfield, New Jersey. No set-aside designation was used for this award.
This BPA call represents a task order for genomic sequencing services that aligns with Genewiz's core capabilities in next-generation sequencing and molecular analysis. As a specialized contract research organization, Genewiz provides critical genomic services to support the National Cancer Institute's research initiatives, including DNA and RNA sequencing, library preparation, and bioinformatics analysis. The National Cancer Institute leverages such genomic services to advance cancer research and characterization efforts across its portfolio of scientific programs, with Genewiz having established itself as a reliable vendor through multiple federal IDIQ contracts with the National Institutes of Health and other agencies within the Department of Health and Human Services.
Quick answers
Who was awarded contract HHSN26100001?
HHSN26100001 was awarded to Genewiz, LLC by National Cancer Institute (National Institutes of Health) on November 2, 2015.
How much is contract HHSN26100001 worth?
The government has obligated $4,998 on HHSN26100001.
Is contract HHSN26100001 an order under another contract?
Yes. HHSN26100001 is a BPA call under HHSN263200700042B, a blanket purchase agreement.
Was contract HHSN26100001 competed?
The extent of competition for HHSN26100001 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award